Stem cell treatment for rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests whether a person's own fat-derived stem cells can reduce inflammation and improve symptoms of rheumatoid arthritis. It aims to provide a new option for people who have not responded to standard medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of rheumatoid arthritis based on standard criteria.
- Your RA must be active, meaning you have at least 6 swollen joints and morning stiffness lasting 45 minutes or longer.
- You must have tried at least one anti-rheumatic drug that didn't work or caused side effects, and be on a stable dose of methotrexate, leflunomide, sulfasalazine, or prednisone for at least 4 weeks.
- You need to be generally healthy, with no active infections, cancer, or severe organ failure.
- You must not be pregnant, breastfeeding, or planning to become pregnant during the study.
- You must be willing to follow study procedures and avoid other investigational treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This clinical trial is testing if infusions of special stem cells (called mesenchymal stem cells) can help people with certain autoimmune diseases where standard treatments have not worked well enough. It is an early-phase study in Pakistan for adults (and some children for one condition) with rheumatoid arthritis, lupus, systemic sclerosis, ankylosing spondylitis, or dermatomyositis/polymyositis.
This Phase 1 trial tests how safe an intravenous (through a vein) stem cell product is for people with rheumatoid arthritis. It is mainly looking for side effects and safety rather than proving it works yet.
This trial tests whether transferring healthy gut bacteria from a donor to patients with rheumatoid arthritis that hasn't improved on standard medications can reduce joint pain and swelling. The goal is to see if rebalancing the gut microbiome (the community of bacteria in your intestines) helps control inflammation.
This trial tests if stem cells can improve pain and swelling in the knee for people with rheumatoid arthritis that hasn't responded well to standard treatments. It's for those who still have significant knee symptoms despite taking medications.
This trial tests whether two natural treatments—one made from your own blood (platelet-rich plasma) and one from your own fat cells—can relieve knee osteoarthritis pain when injected into the knee. The goal is to see if these injections reduce pain and improve knee function without surgery.
This trial tests a joint treatment made from your own platelets (platelet-rich plasma, or PRP) combined with other biologic material (from fat tissue and/or bone marrow) to help osteoarthritis symptoms. It may be an option if you have early-to-moderate osteoarthritis in a major joint and meet safety requirements.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.